FUNDAMENTALS |
MarketCap: |
0.0962 mill
|
EPS: |
0.0200
|
P/E: |
0.100
|
Earnings Date: |
May 24, 2024 |
SharesOutstanding: |
48.10 mill
|
Avg Daily Volume: |
0.0058 mill
|
RATING
2024-04-30 |
C+
|
Sell
|
RATINGS |
Rating CashFlow: |
Sell
|
|
Return On Equity: |
Sell
|
|
Return On Asset: |
Neutral
|
|
DE: |
Sell
|
|
P/E: |
Neutral
|
|
Price To Book: |
Strong Sell
|
|
QUARTER GROWTHS |
|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 |
Revenue | | | | | | n/a |
Gr.Profit | | | | | | n/a |
Ebit | | | | | | n/a |
Asset | | | | | | n/a |
Debt | | | | | | n/a |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE 0.100 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
0x
|
Company: PE 0.100 | industry: PE -2.06
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ 0.0020 - 0.0020
( +/- 0.00%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2021-11-18 | Sternberg Stuart | Buy | 0 | |
2021-10-19 | Sternberg Stuart | Sell | 0 | Common Stock, par value $0.20 per share |
2021-07-15 | Moroney John J | Sell | 495 500 | Common Stock |
2020-07-01 | Davis Chaim | Buy | 35 461 | Common Shares |
2020-07-01 | Neff Jean | Buy | 35 461 | Common Shares |
INSIDER POWER |
0.00
|
Last
92 transactions |
Buy:
5 658 620 | Sell:
695 500 |
Forecast:
11:14 - $0.0020
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
Volume Signals |
Price |
$0.0020 (0.00% )
|
Volume |
0.249 mill
|
Avg. Vol. |
0.0058 mill
|
% of Avg. Vol |
4 327.94 %
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ABMC
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to non-affiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.